Related Experiment Video
Updated: Mar 3, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
A first in human evaluation of a novel contrast media saving device
James Sapontis1, Garry Barron1, Sujith Seneviratne1
1Monash Cardiovascular Research Centre, MonashHeart, Monash Health & Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia.
Insights
The DyeVert System significantly reduces contrast media used in coronary procedures by 47%, maintaining image quality. This innovation helps prevent contrast-induced acute kidney injury (CI-AKI) in patients.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Radiology
Background:
- Contrast media reflux during coronary procedures increases risk of contrast-induced acute kidney injury (CI-AKI).
- CI-AKI is a significant complication associated with increased morbidity, mortality, and healthcare costs.
- Reducing contrast volume is a key modifiable factor for CI-AKI prevention.
Purpose of the Study:
- To evaluate the usability of the DyeVert System.
- To quantify contrast volume savings achieved with the DyeVert System during coronary procedures.
- To assess the impact of the DyeVert System on image quality.
Main Methods:
- A pilot trial involving 44 patients undergoing coronary diagnostic or percutaneous coronary intervention (PCI) procedures.
- Procedures utilized a manual manifold injection setup with the DyeVert System to divert excess contrast.
- Direct measurements of attempted versus actual injected contrast volume were recorded.
Main Results:
- The DyeVert System achieved a mean contrast volume saving of 47% (P < 0.0001), exceeding the 15% target.
- Similar volume savings were observed in both diagnostic (47% ± 9%) and PCI (50% ± 9%) procedures.
- Adequate image quality was maintained in 98% of patients (43/44).
Conclusions:
- The DyeVert System effectively reduces contrast delivery in coronary diagnostic and interventional procedures.
- The system maintains adequate image quality, crucial for accurate diagnosis and treatment.
- This technology offers a promising approach to mitigate CI-AKI risk by lowering contrast volume.
Objectives:
This study evaluated the usability and contrast volume savings of the novel DyeVert™ System.
Background:
During coronary diagnostic and interventional procedures, a substantial portion of injected contrast does not contribute to vessel imaging due to reflux into the ascending aorta. Contrast volume is the primary physician modifiable risk factor for prevention of contrast-induced acute kidney injury CI-AKI which is a frequent complication in patients undergoing coronary angiographic procedures and is related to increases in morbidity, mortality, and healthcare costs.
Methods:
In this pilot trial, 44 patients undergoing coronary diagnostic and/or percutaneous coronary intervention (PCI) procedures were enrolled in two centers. All procedures were conducted using a manual manifold injection setup and the DyeVert System, which facilitates the diversion of excess contrast volume prior to injection into the patient. Direct measurements of both the amount of contrast that was attempted to be injected and the actual volume injected into the patient were taken.
Results:
The difference between the two amounts indicated the volume saved. Procedure types included 34 diagnostic studies and 10 PCI. The mean percent volume saved by the DyeVert System was 47%, with a corresponding P value of <0.0001 achieving the pre-specified level of greater than 15% of contrast media being saved. Mean volume savings were similar for both diagnostic (47 ± 9%) and PCI (50 ± 9%) procedures. Image quality was good in 43/44 (98%) patients.
Conclusions:
The DyeVert System substantially decreases contrast delivered to patients during diagnostic or interventional coronary procedures while maintaining adequate image quality. © 2017 Wiley Periodicals, Inc.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Related Concept Videos
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Cardiac Catheterization I: Pre-Procedure Overview